• Activity INFORMATION

  Overview

  Hyperlipidemia is a common disease state encountered in the clinical setting and guidelines have been recently updated to discuss the role of therapies, therapeutic goals, and other clinical considerations. Using a review of primary medications utilized, including an update of guidelines and key recommendations, this presentation will assist healthcare providers in feeling comfortable with initiating, monitoring, and counseling on these therapies.
  

  Handouts

  • Slide Document :   22275H01_2pp.pdf Download

  • Slide Document :   22275H01_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Identify clinical pears associated with foundational and new hyperlipidemia agents

  Differentiate clinical considerations on the role of therapy for each agent

  Define the key practice points of major cholesterol guidelines

  Nurse

  Identify clinical pears associated with foundational and new hyperlipidemia agents

  Define the key practice points of major cholesterol guidelines

  Differentiate clinical considerations on the role of therapy for each agent

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-942215

  Universal Activity Number

  Pharmacist 0798-0000-22-275-H01-P
  Nurse 0798-0000-22-275-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Megan  Adelman, PharmD, BCPS, BCGP, CDE Family Medicine Pharmacy Specialist, Cleveland Clinic Akron General

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).